|
regulation of meiosis
|
GO:0040020 |
3 |
0.675
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.565
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.559
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.505
|
|
|
gene silencing
|
GO:0016458 |
138 |
0.491
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.389
|
|
|
rna processing
|
GO:0006396 |
147 |
0.378
|
|
|
larval development
|
GO:0002164 |
104 |
0.341
|
|
|
ribonucleoprotein complex assembly
|
GO:0022618 |
23 |
0.340
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.326
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.308
|
|
|
rna localization
|
GO:0006403 |
115 |
0.298
|
|
|
histone h2a acetylation
|
GO:0043968 |
1 |
0.295
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.286
|
|
|
cell division
|
GO:0051301 |
248 |
0.286
|
|
|
axon development
|
GO:0061564 |
297 |
0.259
|
|
|
regulation of rna splicing
|
GO:0043484 |
69 |
0.252
|
|
|
mrna metabolic process
|
GO:0016071 |
124 |
0.247
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.214
|
|
|
cytokinesis
|
GO:0000910 |
90 |
0.208
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.201
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
277 |
0.196
|
|
|
cytoskeleton dependent cytokinesis
|
GO:0061640 |
81 |
0.194
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
73 |
0.183
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
128 |
0.173
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.172
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
73 |
0.172
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.169
|
|
|
lipid storage
|
GO:0019915 |
38 |
0.159
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.151
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
9 |
0.150
|
|
|
nuclear rna surveillance
|
GO:0071027 |
3 |
0.149
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.144
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.140
|
|
|
aging
|
GO:0007568 |
143 |
0.132
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
64 |
0.128
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.126
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.123
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
270 |
0.123
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
251 |
0.122
|
|
|
chromatin silencing
|
GO:0006342 |
76 |
0.119
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.112
|
|
|
regulation of gene silencing
|
GO:0060968 |
63 |
0.112
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.111
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
240 |
0.103
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.096
|
|
|
mitotic spindle organization
|
GO:0007052 |
220 |
0.096
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.094
|
|
|
growth
|
GO:0040007 |
359 |
0.094
|
|
|
gene silencing by rna
|
GO:0031047 |
57 |
0.093
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.089
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
72 |
0.089
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.089
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
73 |
0.088
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.088
|
|
|
chromosome organization
|
GO:0051276 |
360 |
0.081
|
|
|
maintenance of location
|
GO:0051235 |
73 |
0.080
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.076
|
|
|
dna damage checkpoint
|
GO:0000077 |
78 |
0.072
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.071
|
|
|
covalent chromatin modification
|
GO:0016569 |
106 |
0.070
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
45 |
0.065
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
22 |
0.065
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.060
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.058
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.058
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.058
|
|
|
dendrite development
|
GO:0016358 |
204 |
0.056
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.055
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.054
|
|
|
ncrna metabolic process
|
GO:0034660 |
43 |
0.054
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.053
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
145 |
0.053
|
|
|
lipid localization
|
GO:0010876 |
54 |
0.052
|
|
|
positive regulation of cellular protein metabolic process
|
GO:0032270 |
118 |
0.051
|
|
|
axonogenesis
|
GO:0007409 |
290 |
0.051
|
|
|
death
|
GO:0016265 |
284 |
0.051
|
|
|
stem cell maintenance
|
GO:0019827 |
67 |
0.050
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.049
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.048
|
|
|
regulation of mrna processing
|
GO:0050684 |
71 |
0.047
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.047
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
60 |
0.046
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.042
|
|
|
chromatin modification
|
GO:0016568 |
147 |
0.041
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
46 |
0.041
|
|
|
multicellular organismal aging
|
GO:0010259 |
140 |
0.041
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
277 |
0.041
|
|
|
imaginal disc derived wing morphogenesis
|
GO:0007476 |
337 |
0.037
|
|
|
cell death
|
GO:0008219 |
279 |
0.036
|
|
|
ribosomal large subunit biogenesis
|
GO:0042273 |
1 |
0.036
|
|
|
nuclear import
|
GO:0051170 |
51 |
0.036
|
|
|
rna interference
|
GO:0016246 |
27 |
0.035
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
31 |
0.035
|
|
|
regulation of cell proliferation
|
GO:0042127 |
163 |
0.034
|
|
|
regulation of protein modification process
|
GO:0031399 |
112 |
0.034
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.033
|
|
|
neuroblast proliferation
|
GO:0007405 |
74 |
0.033
|
|
|
oocyte differentiation
|
GO:0009994 |
145 |
0.033
|
|
|
histone modification
|
GO:0016570 |
106 |
0.033
|
|
|
nuclear transport
|
GO:0051169 |
72 |
0.032
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
60 |
0.031
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.031
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.029
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.029
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.029
|
|
|
protein localization to nucleus
|
GO:0034504 |
55 |
0.028
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
106 |
0.028
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
21 |
0.027
|
|
|
regulation of embryonic development
|
GO:0045995 |
68 |
0.027
|
|
|
regulation of transport
|
GO:0051049 |
181 |
0.026
|
|
|
dna templated transcription initiation
|
GO:0006352 |
25 |
0.026
|
|
|
tube development
|
GO:0035295 |
244 |
0.026
|
|
|
pole cell migration
|
GO:0007280 |
13 |
0.024
|
|
|
regulation of neurogenesis
|
GO:0050767 |
158 |
0.024
|
|
|
dendrite morphogenesis
|
GO:0048813 |
199 |
0.023
|
|
|
protein localization to organelle
|
GO:0033365 |
82 |
0.022
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.022
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.021
|
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.021
|
|
|
dna conformation change
|
GO:0071103 |
105 |
0.021
|
|
|
determination of adult lifespan
|
GO:0008340 |
137 |
0.021
|
|
|
formation of a compartment boundary
|
GO:0060288 |
4 |
0.021
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
85 |
0.020
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.020
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.020
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.020
|
|
|
tube morphogenesis
|
GO:0035239 |
191 |
0.020
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
56 |
0.019
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
1 |
0.019
|
|
|
centrosome cycle
|
GO:0007098 |
137 |
0.018
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.018
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.017
|
|
|
molting cycle
|
GO:0042303 |
56 |
0.017
|
|
|
rna 3 end processing
|
GO:0031123 |
45 |
0.016
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
105 |
0.016
|
|
|
protein import into nucleus
|
GO:0006606 |
51 |
0.016
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.016
|
|
|
taxis
|
GO:0042330 |
304 |
0.016
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.015
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
86 |
0.015
|
|
|
regulation of ruffle assembly
|
GO:1900027 |
1 |
0.015
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.015
|
|
|
establishment of rna localization
|
GO:0051236 |
47 |
0.015
|
|
|
histone acetylation
|
GO:0016573 |
38 |
0.015
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
258 |
0.015
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
87 |
0.015
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
143 |
0.014
|
|
|
regulation of cell division
|
GO:0051302 |
72 |
0.014
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.014
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.014
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
62 |
0.014
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.014
|
|
|
protein targeting to nucleus
|
GO:0044744 |
51 |
0.014
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
32 |
0.014
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.013
|
|
|
meiotic cytokinesis
|
GO:0033206 |
33 |
0.013
|
|
|
regulation of nuclear division
|
GO:0051783 |
58 |
0.013
|
|
|
imaginal disc derived appendage development
|
GO:0048737 |
399 |
0.013
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
29 |
0.013
|
|
|
snrna metabolic process
|
GO:0016073 |
14 |
0.013
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
38 |
0.013
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
47 |
0.013
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.013
|
|
|
organic substance transport
|
GO:0071702 |
257 |
0.013
|
|
|
single organism nuclear import
|
GO:1902593 |
51 |
0.012
|
|
|
negative regulation of neuroblast proliferation
|
GO:0007406 |
27 |
0.012
|
|
|
ncrna 3 end processing
|
GO:0043628 |
17 |
0.012
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
3 |
0.012
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
37 |
0.012
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
4 |
0.012
|
|
|
central nervous system development
|
GO:0007417 |
201 |
0.012
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
1 |
0.012
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.011
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
45 |
0.011
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.011
|
|
|
cell motility
|
GO:0048870 |
251 |
0.011
|
|
|
developmental pigmentation
|
GO:0048066 |
68 |
0.011
|
|
|
nucleic acid transport
|
GO:0050657 |
46 |
0.011
|
|
|
dendrite guidance
|
GO:0070983 |
21 |
0.011
|
|
|
cell maturation
|
GO:0048469 |
144 |
0.011
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
3 |
0.010
|
|
|
septin ring organization
|
GO:0031106 |
1 |
0.010
|
|
|
organelle localization
|
GO:0051640 |
148 |
0.010
|
|
|
negative regulation of meiotic cell cycle
|
GO:0051447 |
2 |
0.010
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
36 |
0.010
|
|